{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:36:00Z","timestamp":1789670160201,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Anusandhan National Research Foundation","award":["CRG\/2022\/000847-G"],"award-info":[{"award-number":["CRG\/2022\/000847-G"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11190-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:55:57Z","timestamp":1762264557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synergistic neuroprotective effects of Vitexin and Thymol against Okadaic acid-induced neurotoxicity: Computational and In vitro evaluation"],"prefix":"10.1007","volume":"53","author":[{"given":"Sakthivel","family":"Jafni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuvenugopal","family":"Nagakanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balakrishnan","family":"Indhirakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra Kumar Soundarya","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Preethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedagiri","family":"Hemamalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunasekaran","family":"Vanathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundara Dhakshinamurthy","family":"Saraswathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasi Pandima","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"11190_CR1","doi-asserted-by":"publisher","unstructured":"Cummings J, Aisen PS, Dubois B et al (2016) Drug development in alzheimer\u2019s disease: the path to 2025. Alzheimers Res Ther 8. https:\/\/doi.org\/10.1186\/S13195-016-0207-9","DOI":"10.1186\/S13195-016-0207-9"},{"key":"11190_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ENE.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25:59\u201370. https:\/\/doi.org\/10.1111\/ENE.13439","journal-title":"Eur J Neurol"},{"key":"11190_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/life14121555","volume":"14","author":"R Cacabelos","year":"2024","unstructured":"Cacabelos R, Mart\u00ednez-Iglesias O, Cacabelos N et al (2024) Therapeutic options in alzheimer\u2019s disease: from classic acetylcholinesterase inhibitors to Multi-Target drugs with pleiotropic activity. Life 14:1555. https:\/\/doi.org\/10.3390\/life14121555","journal-title":"Life"},{"key":"11190_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","volume":"69","author":"S Wegmann","year":"2021","unstructured":"Wegmann S, Biernat J, Mandelkow E (2021) A current view on Tau protein phosphorylation in alzheimer\u2019s disease. Curr Opin Neurobiol 69:131\u2013138. https:\/\/doi.org\/10.1016\/j.conb.2021.03.003","journal-title":"Curr Opin Neurobiol"},{"key":"11190_CR5","doi-asserted-by":"publisher","unstructured":"Singh A, Ansari VA, Mahmood T et al (2024) Targeting abnormal Tau phosphorylation for alzheimer\u2019s therapeutics. Horm Metab Res 56. https:\/\/doi.org\/10.1055\/A-2238-1384","DOI":"10.1055\/A-2238-1384"},{"key":"11190_CR6","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.medp.2024.100060","volume":"1","author":"J Su","year":"2024","unstructured":"Su J, Xiao Y, Wang X et al (2024) Development of Tau phosphorylation-targeting therapies for the treatment of neurodegenerative diseases. Med Plus 1:100060. https:\/\/doi.org\/10.1016\/j.medp.2024.100060","journal-title":"Med Plus"},{"key":"11190_CR7","doi-asserted-by":"publisher","unstructured":"Tell V, Hilgeroth A (2013) Recent developments of protein kinase inhibitors as potential AD therapeutics. Front Cell Neurosci 7. https:\/\/doi.org\/10.3389\/fncel.2013.00189","DOI":"10.3389\/fncel.2013.00189"},{"key":"11190_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/ptr.8435","volume":"39","author":"RS Bhattacharya","year":"2025","unstructured":"Bhattacharya RS, Singh R, Panghal A et al (2025) Multi-Targeting phytochemicals for alzheimer\u2019s disease. Phytother Res 39:1453\u20131483. https:\/\/doi.org\/10.1002\/ptr.8435","journal-title":"Phytother Res"},{"key":"11190_CR9","doi-asserted-by":"publisher","unstructured":"Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J (2017) Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in alzheimer\u2019s disease. https:\/\/doi.org\/10.1523\/ENEURO.0149-16.2017. eNeuro 4:","DOI":"10.1523\/ENEURO.0149-16.2017"},{"key":"11190_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ntt.2008.11.001","volume":"31","author":"APB Vint\u00e9m","year":"2009","unstructured":"Vint\u00e9m APB, Henriques AG, da Cruz e Silva OAB, da Cruz e Silva EF (2009) PP1 Inhibition by A\u03b2 peptide as a potential pathological mechanism in alzheimer\u2019s disease. Neurotoxicol Teratol 31:85\u201388. https:\/\/doi.org\/10.1016\/j.ntt.2008.11.001","journal-title":"Neurotoxicol Teratol"},{"key":"11190_CR11","doi-asserted-by":"publisher","first-page":"13989","DOI":"10.1523\/JNEUROSCI.2293-15.2015","volume":"35","author":"XD Hu","year":"2015","unstructured":"Hu XD, Liu YN, Zhang ZY et al (2015) Spinophilin-Targeted protein Phosphatase-1 alleviated inflammatory pain by negative control of MEK\/ERK signaling in spinal cord dorsal Horn of rats. J Neurosci 35:13989\u201314001. https:\/\/doi.org\/10.1523\/JNEUROSCI.2293-15.2015","journal-title":"J Neurosci"},{"key":"11190_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/PHYSREV.00028.2011","volume":"92","author":"JM Kyriakis","year":"2012","unstructured":"Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92:689\u2013737. https:\/\/doi.org\/10.1152\/PHYSREV.00028.2011","journal-title":"Physiol Rev"},{"key":"11190_CR13","doi-asserted-by":"publisher","first-page":"20913","DOI":"10.1074\/JBC.M009047200","volume":"276","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Dong Z, Nomura M et al (2001) Signal transduction pathways involved in phosphorylation and activation of p70S6K following exposure to UVA irradiation. J Biol Chem 276:20913\u201320923. https:\/\/doi.org\/10.1074\/JBC.M009047200","journal-title":"J Biol Chem"},{"key":"11190_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.FEBSLET.2005.11.059","volume":"580","author":"JJ Pei","year":"2006","unstructured":"Pei JJ, An WL, Zhou XW et al (2006) P70 S6 kinase mediates Tau phosphorylation and synthesis. FEBS Lett 580:107\u2013114. https:\/\/doi.org\/10.1016\/J.FEBSLET.2005.11.059","journal-title":"FEBS Lett"},{"key":"11190_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","volume":"11","author":"J Biernat","year":"1993","unstructured":"Biernat J, Gustke N, Drewes G et al (1993) Phosphorylation of Ser262 strongly reduces binding of Tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153\u2013163. https:\/\/doi.org\/10.1016\/0896-6273(93)90279-Z","journal-title":"Neuron"},{"key":"11190_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","volume":"10","author":"GT Bramblett","year":"1993","unstructured":"Bramblett GT, Goedert M, Jakes R et al (1993) Abnormal Tau phosphorylation at Ser396 in alzheimer\u2019s disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089\u20131099. https:\/\/doi.org\/10.1016\/0896-6273(93)90057-X","journal-title":"Neuron"},{"key":"11190_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0014-5793(99)00741-3","volume":"454","author":"R Godemann","year":"1999","unstructured":"Godemann R, Biernat J, Mandelkow E, Mandelkow EM (1999) Phosphorylation of Tau protein by Recombinant GSK-3\u03b2: pronounced phosphorylation at select Ser\/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett 454:157\u2013164. https:\/\/doi.org\/10.1016\/S0014-5793(99)00741-3","journal-title":"FEBS Lett"},{"key":"11190_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neulet.2003.09.037","volume":"353","author":"Y Yoshimura","year":"2003","unstructured":"Yoshimura Y, Ichinose T, Yamauchi T (2003) Phosphorylation of Tau protein to sites found in alzheimer\u2019s disease brain is catalyzed by Ca2+\/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci Lett 353:185\u2013188. https:\/\/doi.org\/10.1016\/j.neulet.2003.09.037","journal-title":"Neurosci Lett"},{"key":"11190_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/J.1471-4159.2008.05716.X","volume":"108","author":"G Sadik","year":"2009","unstructured":"Sadik G, Tanaka T, Kato K et al (2009) Phosphorylation of Tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of Tau aggregation. J Neurochem 108:33\u201343. https:\/\/doi.org\/10.1111\/J.1471-4159.2008.05716.X","journal-title":"J Neurochem"},{"key":"11190_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0002-9440(10)63444-X","volume":"163","author":"S Kins","year":"2003","unstructured":"Kins S, Kurosinski P, Nitsch RM, G\u00f6tz J (2003) Activation of the ERK and JNK signaling pathways caused by Neuron-Specific Inhibition of PP2A in Transgenic mice. Am J Pathol 163:833. https:\/\/doi.org\/10.1016\/S0002-9440(10)63444-X","journal-title":"Am J Pathol"},{"key":"11190_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","volume":"45","author":"B Turgutalp","year":"2024","unstructured":"Turgutalp B, Kizil C (2024) Multi-target drugs for alzheimer\u2019s disease. Trends Pharmacol Sci 45:628\u2013638. https:\/\/doi.org\/10.1016\/j.tips.2024.05.005","journal-title":"Trends Pharmacol Sci"},{"key":"11190_CR22","doi-asserted-by":"publisher","unstructured":"Guo J, Wang Z, Liu R et al (2020) Memantine, Donepezil, or combination Therapy\u2014What is the best therapy for alzheimer\u2019s disease? A network Meta-Analysis. https:\/\/doi.org\/10.1002\/brb3.1831. Brain Behav 10:","DOI":"10.1002\/brb3.1831"},{"key":"11190_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"PN Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT et al (2004) Memantine treatment in patients with moderate to severe alzheimer disease already receiving donepezil. JAMA 291:317. https:\/\/doi.org\/10.1001\/jama.291.3.317","journal-title":"JAMA"},{"key":"11190_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/NBT.1549;KWRD","volume":"27","author":"J Leh\u00e1r","year":"2009","unstructured":"Leh\u00e1r J, Krueger AS, Avery W et al (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27:659\u2013666. https:\/\/doi.org\/10.1038\/NBT.1549;KWRD","journal-title":"Nat Biotechnol"},{"key":"11190_CR25","doi-asserted-by":"publisher","unstructured":"Mehta M, Adem A, Sabbagh M (2012) New acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Int J Alzheimers Dis 2012:. https:\/\/doi.org\/10.1155\/2012\/728983","DOI":"10.1155\/2012\/728983"},{"key":"11190_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/S12031-014-0288-5","volume":"53","author":"S Mak","year":"2014","unstructured":"Mak S, Luk WWK, Cui W et al (2014) Synergistic Inhibition on acetylcholinesterase by the combination of Berberine and palmatine originally isolated from Chinese medicinal herbs. J Mol Neurosci 53:511\u2013516. https:\/\/doi.org\/10.1007\/S12031-014-0288-5","journal-title":"J Mol Neurosci"},{"key":"11190_CR27","doi-asserted-by":"publisher","unstructured":"Balkrishna A, Pokhrel S, Tomer M et al (2019) Anti-Acetylcholinesterase activities of Mono-Herbal extracts and exhibited synergistic effects of the phytoconstituents: A biochemical and computational study. Molecules 24. https:\/\/doi.org\/10.3390\/MOLECULES24224175","DOI":"10.3390\/MOLECULES24224175"},{"key":"11190_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21315\/MJMS2023.30.2.2","volume":"30","author":"M Mustapha","year":"2022","unstructured":"Mustapha M, Taib CNM (2022) Beneficial role of vitexin in parkinson\u2019s disease. Malays J Med Sci 30:8. https:\/\/doi.org\/10.21315\/MJMS2023.30.2.2","journal-title":"Malays J Med Sci"},{"key":"11190_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/J.TIV.2018.03.003","volume":"50","author":"DS Malar","year":"2018","unstructured":"Malar DS, Suryanarayanan V, Prasanth MI et al (2018) Vitexin inhibits A\u03b225\u201335 induced toxicity in Neuro-2a cells by augmenting Nrf-2\/HO-1 dependent antioxidant pathway and regulating lipid homeostasis by the activation of LXR-\u03b1. Toxicol Vitro 50:160\u2013171. https:\/\/doi.org\/10.1016\/J.TIV.2018.03.003","journal-title":"Toxicol Vitro"},{"key":"11190_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/J.LFS.2018.04.047","volume":"203","author":"DS Malar","year":"2018","unstructured":"Malar DS, Prasanth MI, Shafreen RB et al (2018) Grewia tiliaefolia and its active compound vitexin regulate the expression of glutamate transporters and protect Neuro-2a cells from glutamate toxicity. Life Sci 203:233\u2013241. https:\/\/doi.org\/10.1016\/J.LFS.2018.04.047","journal-title":"Life Sci"},{"key":"11190_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/S11011-016-9921-Z","volume":"32","author":"H Li","year":"2017","unstructured":"Li H, Qin T, Li M, Ma S (2017) Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2\/HO-1 pathway. Metab Brain Dis 32:385\u2013393. https:\/\/doi.org\/10.1007\/S11011-016-9921-Z","journal-title":"Metab Brain Dis"},{"key":"11190_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/J.BRAINRESBULL.2018.01.008","volume":"137","author":"M Asadbegi","year":"2018","unstructured":"Asadbegi M, Komaki A, Salehi I et al (2018) Effects of thymol on amyloid-\u03b2-induced impairments in hippocampal synaptic plasticity in rats fed a high-fat diet. Brain Res Bull 137:338\u2013350. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2018.01.008","journal-title":"Brain Res Bull"},{"key":"11190_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/SREP42717;TECHMETA","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:1\u201313. https:\/\/doi.org\/10.1038\/SREP42717;TECHMETA","journal-title":"Sci Rep"},{"key":"11190_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/J.NEURON.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99:1129\u20131143. https:\/\/doi.org\/10.1016\/J.NEURON.2018.08.011","journal-title":"Neuron"},{"key":"11190_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/PTR.2063","volume":"21","author":"M Jukic","year":"2007","unstructured":"Jukic M, Politeo O, Maksimovic M et al (2007) In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res 21:259\u2013261. https:\/\/doi.org\/10.1002\/PTR.2063","journal-title":"Phytother Res"},{"key":"11190_CR36","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/BIOMEDICINES9111689\/S1","volume":"9","author":"MPG Moreta","year":"2021","unstructured":"Moreta MPG, Burgos-Alonso N, Torrecilla M et al (2021) Efficacy of acetylcholinesterase inhibitors on cognitive function in alzheimer\u2019s disease. Rev Reviews Biomedicines 9:1689. https:\/\/doi.org\/10.3390\/BIOMEDICINES9111689\/S1","journal-title":"Rev Reviews Biomedicines"},{"key":"11190_CR37","doi-asserted-by":"crossref","unstructured":"Kamat P, Research CN-N regeneration (2015) undefined Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in alzheimer\u2019s disease. journals.lww.com","DOI":"10.4103\/1673-5374.153679"},{"key":"11190_CR38","doi-asserted-by":"crossref","unstructured":"Yu Y, Pei F, Wellness ZL-FS and H (2022) Undefined Orientin and vitexin attenuate lipopolysaccharide-induced inflammatory responses in RAW264. 7 cells: a molecular docking study, biochemical. ElsevierY Yu, F Pei, Z LiFood Science and Human Wellness, 2022\u2022Elsevier","DOI":"10.1016\/j.fshw.2022.04.024"},{"key":"11190_CR39","doi-asserted-by":"publisher","unstructured":"Chen P, Chang Y, Tsai K Vitexin suppresses High-Glucose-upregulated adhesion molecule expression in endothelial cells through inhibiting NF-\u03baB signaling pathway. ACS PublicationsPC Chen, Chang YC, Tsai KL, Shen CH et al (2024) SD LeeACS omega, 2024\u2022ACS Publications. https:\/\/doi.org\/10.1021\/ACSOMEGA.4C02545","DOI":"10.1021\/ACSOMEGA.4C02545"},{"key":"11190_CR40","doi-asserted-by":"publisher","unstructured":"Chen Y, Yang J, Huang Z et al (2022) Vitexin mitigates Staphylococcus aureus-Induced mastitis via regulation of ROS\/ER Stress\/NF\u2010\u03baB\/MAPK pathway. https:\/\/doi.org\/10.1155\/2022\/7977433. Wiley Online Library 2022:","DOI":"10.1155\/2022\/7977433"},{"key":"11190_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/S10753-013-9732-X","volume":"37","author":"D Liang","year":"2014","unstructured":"Liang D, Li F, Fu Y, Li F, Fu Y, Cao Y, Song X, Wang T, Wang W, Guo M, Zhou E, Li D, Yang Z, ZhangInflammation N et al (2014) 2014\u2022Springer 37:214\u2013222. https:\/\/doi.org\/10.1007\/S10753-013-9732-X","journal-title":"2014\u2022Springer"},{"key":"11190_CR42","doi-asserted-by":"publisher","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7. https:\/\/doi.org\/10.1038\/SREP42717","DOI":"10.1038\/SREP42717"},{"key":"11190_CR43","doi-asserted-by":"publisher","unstructured":"Gfeller D, Grosdidier A, Wirth M et al (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res 42. https:\/\/doi.org\/10.1093\/NAR\/GKU293","DOI":"10.1093\/NAR\/GKU293"},{"key":"11190_CR44","doi-asserted-by":"publisher","first-page":"13950","DOI":"10.1080\/07391102.2023.2203259","volume":"41","author":"S Muthumanickam","year":"2023","unstructured":"Muthumanickam S, Ramachandran B, Boomi P et al (2023) Combination of bendamustine-azacitidine against Syk target of breast cancer: an in Silico study. J Biomol Struct Dyn 41:13950\u201313962. https:\/\/doi.org\/10.1080\/07391102.2023.2203259","journal-title":"J Biomol Struct Dyn"},{"key":"11190_CR45","doi-asserted-by":"publisher","unstructured":"Bowers KJ, Chow E, Xu H et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. dl.acm.orgKJ Bowers, E Chow, H Xu, RO Dror, MP Eastwood, BA Gregersen, JL Klepeis, I KolossvaryProceedings of the 2006 ACM\/IEEE Conference on Supercomputing, 2006\u2022dl.acm.org. https:\/\/doi.org\/10.1145\/1188455.1188544","DOI":"10.1145\/1188455.1188544"},{"key":"11190_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/09670262.2016.1218938","volume":"51","author":"B Shanmuganathan","year":"2016","unstructured":"Shanmuganathan B, Pandima Devi K (2016) Evaluation of the nutritional profile and antioxidant and anti-cholinesterase activities of Padina gymnospora (Phaeophyceae). Eur J Phycol 51:482\u2013490. https:\/\/doi.org\/10.1080\/09670262.2016.1218938","journal-title":"Eur J Phycol"},{"key":"11190_CR47","doi-asserted-by":"publisher","unstructured":"Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols 2006 1:3 1:1112\u20131116. https:\/\/doi.org\/10.1038\/nprot.2006.179","DOI":"10.1038\/nprot.2006.179"},{"key":"11190_CR48","doi-asserted-by":"crossref","unstructured":"Shanmuganathan B, Sathya S, Oxide BB-N (2019)\u00a0Undefined Amyloid-\u03b2 induced neuropathological actions are suppressed by Padina gymnospora (Phaeophyceae) and its active constituent \u03b1-bisabolol in Neuro2a cells and\u00a0. Elsevier","DOI":"10.1016\/j.niox.2019.07.009"},{"key":"11190_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2174\/0118715206289038240214102951","volume":"24","author":"C Kiruthiga","year":"2024","unstructured":"Kiruthiga C, Niharika K, Devi KP (2024) Phytol and \u03b1-Bisabolol synergy induces autophagy and apoptosis in A549 cells and additional molecular insights through comprehensive proteome analysis via nano LC-MS\/MS. Anticancer Agents Med Chem 24:773\u2013788. https:\/\/doi.org\/10.2174\/0118715206289038240214102951","journal-title":"Anticancer Agents Med Chem"},{"key":"11190_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/ph17030341","volume":"17","author":"W Inthachat","year":"2024","unstructured":"Inthachat W, Chantong B, Pitchakarn P et al (2024) Enhancing therapeutic efficacy of Donepezil, an alzheimer\u2019s disease Drug, by diplazium esculentum (Retz.) Sw. and its phytochemicals. Pharmaceuticals 17:341. https:\/\/doi.org\/10.3390\/ph17030341","journal-title":"Pharmaceuticals"},{"key":"11190_CR51","doi-asserted-by":"publisher","unstructured":"Asle-Rousta M (2025) The neuroprotective properties of thymol and carvacrol: A review study. Nat Prod J 15. https:\/\/doi.org\/10.2174\/0122103155288752240219095244","DOI":"10.2174\/0122103155288752240219095244"},{"key":"11190_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/NRD.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15:275\u2013292. https:\/\/doi.org\/10.1038\/NRD.2015.21","journal-title":"Nat Rev Drug Discov"},{"key":"11190_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/BCPT.14073","author":"N Joshi","year":"2024","unstructured":"Joshi N, Vaidya B, Sharma SS (2024) Transient receptor potential channels as an emerging target for the treatment of alzheimer\u2019s disease: unravelling the potential of Pharmacological interventions. Basic Clin Pharmacol Toxicol. https:\/\/doi.org\/10.1111\/BCPT.14073","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"11190_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/J.BRAINRES.2018.11.042","volume":"1707","author":"E Ambrad Giovannetti","year":"2019","unstructured":"Ambrad Giovannetti E, Fuhrmann M (2019) Unsupervised excitation: GABAergic dysfunctions in alzheimer\u2019s disease. Brain Res 1707:216\u2013226. https:\/\/doi.org\/10.1016\/J.BRAINRES.2018.11.042","journal-title":"Brain Res"},{"key":"11190_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1567205052772713","volume":"2","author":"I Ferrer","year":"2005","unstructured":"Ferrer I, Gomez-Isla T, Puig B et al (2005) Current advances on different kinases involved in Tau phosphorylation, and implications in alzheimer\u2019s disease and Tauopathies. Curr Alzheimer Res 2:3\u201318. https:\/\/doi.org\/10.2174\/1567205052772713","journal-title":"Curr Alzheimer Res"},{"key":"11190_CR56","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/07391102.2023.2192806","volume":"42","author":"E Uzunhisarc\u0131kl\u0131","year":"2024","unstructured":"Uzunhisarc\u0131kl\u0131 E, \u00c7elik \u0130, Yerer MB (2024) Detection of natural compounds by virtual screening, molecular Docking and dynamics studies and evaluation of their effects on Tau level in vitro alzheimer\u2019s model. J Biomol Struct Dyn 42:384\u2013392. https:\/\/doi.org\/10.1080\/07391102.2023.2192806","journal-title":"J Biomol Struct Dyn"},{"key":"11190_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/JNC.12059","volume":"124","author":"SH Choi","year":"2013","unstructured":"Choi SH, Aid S, Caracciolo L et al (2013) Cyclooxygenase-1 Inhibition reduces amyloid pathology and improves memory deficits in a mouse model of alzheimer\u2019s disease. J Neurochem 124:59\u201368. https:\/\/doi.org\/10.1111\/JNC.12059","journal-title":"J Neurochem"},{"key":"11190_CR58","doi-asserted-by":"publisher","unstructured":"Sa\u0142aciak K, Kosza\u0142ka A, \u017bmudzka E, Pytka K (2021) The Calcium\/Calmodulin-Dependent kinases II and IV as therapeutic targets in neurodegenerative and neuropsychiatric disorders. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/IJMS22094307","DOI":"10.3390\/IJMS22094307"},{"key":"11190_CR59","doi-asserted-by":"publisher","unstructured":"Lima LKF, Pereira SKS, Junior R dos SS, et al (2018) A brief review on the neuroprotective mechanisms of vitexin. Biomed Res Int 2018:1\u20138. https:\/\/doi.org\/10.1155\/2018\/4785089","DOI":"10.1155\/2018\/4785089"},{"key":"11190_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12896-021-00697-4","volume":"21","author":"MAF Yahaya","year":"2021","unstructured":"Yahaya MAF, Bakar ARA, Stanslas J et al (2021) Insights from molecular Docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation. BMC Biotechnol 21:38. https:\/\/doi.org\/10.1186\/s12896-021-00697-4","journal-title":"BMC Biotechnol"},{"key":"11190_CR61","doi-asserted-by":"publisher","first-page":"154821","DOI":"10.1016\/J.PHYMED.2023.154821","volume":"115","author":"MM Gravandi","year":"2023","unstructured":"Gravandi MM, Abdian S, Tahvilian M et al (2023) Therapeutic targeting of Ras\/Raf\/MAPK pathway by natural products: A systematic and mechanistic approach for neurodegeneration. Phytomedicine 115:154821. https:\/\/doi.org\/10.1016\/J.PHYMED.2023.154821","journal-title":"Phytomedicine"},{"key":"11190_CR62","doi-asserted-by":"publisher","unstructured":"De P, Alzheimer\u2019s KR-CM, of DA (2023), undefined (2023) Computational ModelingKinase Inhibitors as Anti-Alzheimer Agents. SpringerP De, K RoyComputational ModelingDrugs Against Alzheimer\u2019s Disease, 2023\u2022Springer 203:127\u2013163. https:\/\/doi.org\/10.1007\/978-1-0716-3311-3_5","DOI":"10.1007\/978-1-0716-3311-3_5"},{"key":"11190_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/S12906-018-2140-X","author":"M Penumala","year":"2018","unstructured":"Penumala M, Zinka RB, Shaik JB et al (2018) Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for alzheimer\u2019s disease and diabetes mellitus dual therapy. BMC Complement Altern Med. https:\/\/doi.org\/10.1186\/S12906-018-2140-X. 18:","journal-title":"BMC Complement Altern Med"},{"key":"11190_CR64","doi-asserted-by":"publisher","unstructured":"Olasehinde TA, Olaniran AO, Okoh AI (2021) Cholinesterase inhibitory activity, antioxidant properties, and phytochemical composition of Chlorococcum sp. extracts. J Food Biochem 45. https:\/\/doi.org\/10.1111\/JFBC.13395","DOI":"10.1111\/JFBC.13395"},{"key":"11190_CR65","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.3390\/molecules24224175","volume":"24","author":"A Balkrishna","year":"2019","unstructured":"Balkrishna A, Pokhrel S, Tomer M et al (2019) Anti-Acetylcholinesterase activities of Mono-Herbal extracts and exhibited synergistic effects of the phytoconstituents: A biochemical and computational study. Molecules 24:4175. https:\/\/doi.org\/10.3390\/molecules24224175","journal-title":"Molecules"},{"key":"11190_CR66","doi-asserted-by":"publisher","unstructured":"Abdul Manap AS, Wei Tan AC, Leong WH et al (2019) Synergistic effects of Curcumin and Piperine as potent acetylcholine and amyloidogenic inhibitors with significant neuroprotective activity in SH-SY5Y cells via computational molecular modeling and in vitro assay. Front Aging Neurosci 11. https:\/\/doi.org\/10.3389\/fnagi.2019.00206","DOI":"10.3389\/fnagi.2019.00206"},{"key":"11190_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0002-9440(10)63445-1","volume":"163","author":"JJ Pei","year":"2003","unstructured":"Pei JJ, Gong CX, An WL et al (2003) Okadaic-acid-induced Inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1\/2, MEK1\/2, and p70 S6, similar to that in alzheimer\u2019s disease. Am J Pathol 163:845\u2013858. https:\/\/doi.org\/10.1016\/S0002-9440(10)63445-1","journal-title":"Am J Pathol"},{"key":"11190_CR68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuro.2013.05.002","volume":"37","author":"PK Kamat","year":"2013","unstructured":"Kamat PK, Rai S, Nath C (2013) Okadaic acid induced neurotoxicity: an emerging tool to study alzheimer\u2019s disease pathology. Neurotoxicology 37:163\u2013172. https:\/\/doi.org\/10.1016\/j.neuro.2013.05.002","journal-title":"Neurotoxicology"},{"key":"11190_CR69","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.fshw.2022.04.024","volume":"11","author":"Y Yu","year":"2022","unstructured":"Yu Y, Pei F, Li Z (2022) Orientin and vitexin attenuate lipopolysaccharide-induced inflammatory responses in RAW264.7 cells: a molecular Docking study, biochemical characterization, and mechanism analysis. Food Sci Hum Wellness 11:1273\u20131281. https:\/\/doi.org\/10.1016\/j.fshw.2022.04.024","journal-title":"Food Sci Hum Wellness"},{"key":"11190_CR70","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c02545","author":"P-C Chen","year":"2024","unstructured":"Chen P-C, Chang Y-C, Tsai K-L et al (2024) Vitexin suppresses High-Glucose-upregulated adhesion molecule expression in endothelial cells through inhibiting NF-\u03baB signaling pathway. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.4c02545","journal-title":"ACS Omega"},{"key":"11190_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7977433","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yang J, Huang Z et al (2022) Vitexin Mitigates Staphylococcus aureus -Induced Mastitis via Regulation of ROS\/ER Stress\/NF\u2010 \u03ba B\/MAPK Pathway. Oxid Med Cell Longev 2022. https:\/\/doi.org\/10.1155\/2022\/7977433","journal-title":"Oxid Med Cell Longev 2022"},{"key":"11190_CR72","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/J.1460-9568.2005.04391.X","volume":"22","author":"F Liu","year":"2005","unstructured":"Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of Tau phosphorylation. Eur J Neurosci 22:1942\u20131950. https:\/\/doi.org\/10.1111\/J.1460-9568.2005.04391.X","journal-title":"Eur J Neurosci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11190-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:55:59Z","timestamp":1762264559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11190-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11190"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11190-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical Trial number : Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"43"}}